Polanco’s rehab plan has the Mets weighing when to activate him, while Alvarez’s minor-league progress could alter roster depth soon. Fans want clarity: When exactly is Polanco likely back, how will teams balance rehab thresholds with a push to the majors, and what can we expect from Alvarez in the near term? Below are quick, clear Q&As built from the latest reporting and team notes to help you follow the story day by day.
Polanco has been sidelined since mid-April with left Achilles bursitis and a wrist bruise. He’s been in a rehab stint in the minors, but the Mets are prioritizing rehab thresholds before activation. Expect updates as the team evaluates how his legs and wrist respond, with potential activation tied to meeting specific performance and medical benchmarks rather than a fixed date.
Teams weigh several factors: medical clearance, pain thresholds, functional testing, and game readiness. The goal is to avoid setbacks and protect long-term value. In Polanco’s case, the Mets are monitoring thresholds in the minors before moving him to the big league roster, balancing sunk roster costs with the need for a productive return.
Alvarez has resumed activities as part of a minor-league rehab plan. The Mets are evaluating where he fits—behind the plate or at DH—as they navigate injuries and roster depth. A debut could come if his rehab progresses smoothly and a need arises at the major-league level, but specifics depend on ongoing assessments.
Yes. Polanco’s role as a first-base option in place of Alonso (who is not on the roster) has implications for lineup balance and defensive alignment. The Mets are weighing how a delayed return might impact roster construction, contingency plans, and the NL East push.
Key milestones include Polanco clearing medical and rehab thresholds, a tempo-friendly rehab assignment update, Alvarez showing progress in the minors, and potential roster moves once a clear return path emerges. Expect official team notes on activation timelines to follow any new rehab outcomes.
AP News highlighted the thresholds guiding Polanco’s activation, while the NY Post discussed broader roster implications and Alvarez’s rehab timeline. Together, they suggest the Mets are prioritizing cautious progression to avoid guarding against a relapse while keeping an eye on NL East competitiveness.
Jorge Polanco could be the face of these Mets. He’s highly paid, has been injured and played poorly when he was on the field. But his return is near.